Introduction
Chronic myeloid leukemia (CML) is characterized by the BCR-ABL rearrangement that is mostly due to a translocation between the long arm of chromosome 9 and the long arm of chromosome 22. 1 The BCR-ABL gene encodes a chimeric protein with elevated tyrosine kinase activity, 2 which plays an important role in the pathogenesis of the disease. 3 The genetic defect in CML can be detected at the level of chromosomes, the fusion gene, the chimeric RNA or altered structure of the protein. Cytogenetics is still the gold standard for the diagnosis and follow-up of CML patients. About 95% of patients show a standard Philadelphia translocation. The remaining 5% have either more complex translocations involving other chromosomes besides chromosomes 9 and 22 or cryptic BCR-ABL rearrangements that are only detectable at the submicroscopic level. 4 Using fluorescence in situ hybridization (FISH) with probes for BCR and ABL the standard Philadelphia translocation, complex translocations as well as cryptic BCR-ABL rearrangements can be directly visualized in interphase nuclei as well as on metaphases. 5 A third method used in routine diagnosis of CML is RT-PCR detecting the chimeric BCR-ABL mRNA. 6 Southern blot analysis and the detection of the chimeric BCR-ABL protein by Western blot are less often performed for routine purposes. 7, 8 The major advantage of chromosome analysis compared to FISH and RT-PCR is the possibility of detecting chromosome aberrations in addition to the Philadelphia translocation that may have prognostic impact. 9, 10 On the other hand, chromosome banding analysis is cumbersome, time-consuming, labor-intensive and dependent on high numbers of viable, dividing cells. For FISH and RT-PCR less cells are needed and also cryptic BCR-ABL rearrangements that are missed by banding studies can be detected. Furthermore, RT-PCR based techniques are about 1000-to 10 000-fold more sensitive in picking up residual CML cells. This is important for follow-up studies after therapy.
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Recently two new techniques were introduced into CML diagnostics. Seong et al 12 described a method called hypermetaphase FISH, which combines a modified preparation of metaphases with FISH. Due to the higher number of analyzable metaphases the sensitivity is increased compared to classical cytogenetics and also quantification becomes more exact. Quantitative competitive RT-PCR assays have also been established. 11, 13 Real-time PCR procedures have been developed that promise to simplify the time-consuming competitive PCR and allow a reliable and sensitive quantification of BCR-ABL transcripts. 14, 15 In order to evaluate the advantages and disadvantages of each technique at different stages of disease, we performed a study analyzing CML cases in parallel with chromosome analysis (CA), interphase-FISH (IP-FISH), hypermetaphase-FISH (HM-FISH), qualitative RT-PCR and real-time PCR.
Patients and methods

Patients
Three hundred and fifty patients with CML at various stages of therapy were entered into the study. In 10 of these patients a Ph-negative, BCR-ABL-positive CML was diagnosed. These patients were excluded in analyses correlating cytogenetics with other methods because no determination of the BCR-ABL rearrangements is possible with cytogenetics.
Cytogenetics
Chromosome analyses were performed on bone marrow samples. Cells were cultured in RPMI 1640 medium (Gibco, Leukemia Gaithersburg, MD, USA) with 20% fetal calf serum and the addition of antibiotics and antimycotics. Four cultures were set up in parallel for each patient: two cultures without further supplements and two cultures with the addition of a cytokine cocktail (CC) containing erythropoietin, G-CSF, GM-CSF, SCF and IL-3. One plain culture (R24) and one stimulated culture (R24+CC) were cultivated for 24 h, colcemid was added for 2 h followed by standard slide preparation. The other two cultures were cultivated for 24 h without colcemid and then another 24 h after the addition of colcemid (R24 HMF 24, R24+CC HMF 24) followed by standard slide preparation. Metaphases were analyzed for G-bands using a modified GAG-banding technique as described elsewhere. 16 Twentyfive metaphases were analyzed. If less than 10 analyzable metaphases were available, this was judged as not evaluable. The chromosomes were interpreted according to the International System for Human Cytogenetic Nomenclature (ISCN 1995) . 17 Cytogenetic response to therapy was defined relative to the percentage of Ph + metaphases identified by chromosome banding analysis: complete if 0%, partial if from 1% to 34%, minor if from 35% to 95% and none if greater than 95% Ph + metaphases were detected. 18 
Hypermetaphase studies
To test the new technique we studied bone marrow of five normal individuals and 20 CML patients in order to optimize conditions for hypermetaphase preparations in analogy to Seong et al. 12 In the five normal individuals eight cultures were set up in parallel. All cultures were incubated at 37°C for 24 h. Then colcemid was added for different time periods: 2 h, 24 h, 48 h and 72 h, respectively. Furthermore, to one set of cultures a cytokine cocktail consisting of erythropoietin, G-CSF, GM-CSF, SCF and IL-3 was added from the beginning of cultures. The cultures without cytokine stimulation and a 2 h colcemid exposure yielded a median number of 71 metaphases per slide while in the corresponding culture with the addition of the cytokine cocktail a median of 110 metaphases was obtained. Prolonging the colcemid exposure to 24 h led to an increase of the median metaphase number to 536 in the unstimulated and 702 in the cytokine stimulated culture, respectively. With further extension of the colcemid exposure to 48 h the median metaphase number dropped to 42 and 87, respectively, and even more with a 72 h colcemid exposure to 13 and 10, respectively. The four best culture conditions, 2 h and 24 h colcemid exposure ± cytokine cocktail were used for further studies in all 350 patients reported here. Hypermetaphase-FISH was carried out on slides from the hypermetaphase preparation with the addition of the cytokine cocktail.
FISH on interphase nuclei and metaphases
FISH was performed on interphase nuclei on bone marrow smears or on slides prepared for cytogenetic analysis. Metaphase-FISH was carried out on slides prepared from the hypermetaphase preparations. For interphase-FISH 200 interphase nuclei were evaluated. For metaphase-FISH an area of 18 × 18 mm was hybridized. All available metaphases were evaluated for BCR-ABL positivity.
FISH was performed using commercially available BCR-ABL probes (Vysis, Downers Grove, IL, USA). Both probes hybridize to the BCR-ABL fusion gene resulting in one green/red fusion signal. The signals were viewed with a Zeiss Axioskop (Zeiss, Jena, Germany). For documentation the analyzing system ISIS (MetaSystems, Altlussheim, Germany) was used.
To determine the rate of false positive interphases (cut off level) five bone marrow smears and five cytogenetic preparations obtained from normal healthy donors or patients with non-Hodgkin's lymphomas were analyzed. Five hundred interphase nuclei were scored on each slide. The cut-off level was determined as mean + 2 standard deviations = 5.0%. For metaphase-FISH five hypermetaphase preparations of normal healthy donors or lymphoma patients were scored. As no BCR-ABL-positive metaphases were observed the cut-off level was set at 0%.
RNA isolation
Samples were received either locally or by mail and spent between 2 h to 3 days before preparation. Total leukocytes were yielded by erythrocyte lysis of bone marrow or peripheral blood in 3 volumes of lysis buffer (NH 4 CH, 155 mmol/l; KHCO 3 , 10 mmol/l; TitriplexII, 0.13 mmol/l) for 10 min incubation at room temperature. After centrifugation the cell pellet was again resolved in lysis puffer and subsequently centrifuged. 10 7 cells were lysed in RLT-buffer (Qiagen, Hilden, Germany). RNA was extracted with a RNeasy-kit (Qiagen) according to the manufacturer's instructions. RNA was eluted in 50 l of elution buffer.
Reverse transcription
Twenty-five l of the RNA, an equivalent quantity of 5 × 10 6 cells or about 10 g of RNA were reverse transcribed in a 40 l reaction using 300 U of Superscript (LifeTechnologies, Karlsruhe, Germany) and random hexamers (Pharmacia, Freiburg, Germany).
RT-PCR
At diagnosis the BCR-ABL transcript type was determined by conventional PCR in a 35 cycle reaction (1 min 94°C, 1 min 60°C, 1 min 72°C), in 50 l with 10 pmol of each primer, 19 10 mmol dNTPs, and 1.25 units of Taq polymerase (Life Technologies) in the buffer shipped by the supplier. For each sample an cABL-specific RT-PCR was performed to control the integrity of DNA or RNA using primers abl5′: 5′-GGCCAG-TAGCATCTGACTTTG-3′ and abl3′: 5′-ATGGTACCAG-GAGTGTTTCTCC-3′. Strict precautions were taken to prevent contamination. Water instead of cDNA was included as a blank sample in each experiment. Amplification products were analyzed on 1.5% agarose gels stained with ethidium bromide. Nested RT-PCR was performed with a sensitivity of 10 −5 using limited dilution experiments.
Real-time PCR
Light-cycler PCR was performed with 2 l of cDNA in a 20 l reaction as has been described previously 14 with the modification of using FAST-Start LightCycler DNA Master Hybridization Probes (Roche Diagnostics, Mannheim, Germany). Standards consisted of 1000 pg, 10 pg, and 1 pg of .
Statistical methods
Correlation coefficients and P values were calculated according to Spearman using the software STATISTICA (StatSoft Incorp., Tulsa, OK, USA).
Results
Patient characteristics
Bone marrow of 350 patients with CML at different stages of the disease was evaluated in this study. Patients characteristics are reported in Tables 1 and 2 . Table 1 shows the treatment that had been applied in this patient population.
Cytogenetics
A median of 25 metaphases and a mean of 23 metaphases were analyzed in every patient (range 2 to 44 metaphases). In five of 350 patients less than 10 metaphases could be analyzed with chromosome banding. These patients were judged as not evaluable for cytogenetics. Ten patients were BCR-ABL positive but showed no Philadelphia translocation. These patients were excluded from comparing analyses. 
Leukemia
In 272 cases the standard Philadelphia translocation was the sole abnormality, 18 cases showed a variant Philadelphia translocation and in 50 cases further chromosome abnormalities were observed in addition to the Philadelphia translocation. Table 2 demonstrates the cytogenetic remission status according to CA in comparison to HM-FISH.
Hypermetaphase-FISH
With HM-FISH a median of 54 and a mean of 97 metaphases (range 1 to 521) were evaluated. In 29 of 350 (8.3%) patients studied, less than 10 metaphases could be analyzed. These patients were judged as not evaluable by this technique. Compared to CA the rate of not evaluable patients was higher in HM-FISH (1.4% vs 8.3%). This is due to the fact that only half a slide was hybridized for HM-FISH, while up to 10 whole slides were evaluated for CA.
Interphase-FISH
In all 350 patients 200 interphase nuclei were evaluated for BCR-ABL positivity. One hundred and seven samples were judged as negative because the percentage of BCR-ABLpositive nuclei was below the cut-off level of 5% determined in our laboratory.
Interphase-FISH on bone marrow smears compared to cultured cells
In 70 patients interphase FISH was performed on bone marrow smears and on cells that had been cultivated for 48 h with cytokines added to the medium as for the preparation of hypermetaphases. The results of IP-FISH showed a good correlation (r = 0.86) but especially in patients with more than 30% of BCR-ABL-positive interphase nuclei a tendency to a higher percentage of BCR-ABL-positive cells was observed after cultivation ( Figure 1) . Therefore, accumulation of BCR-
Figure 1
Correlation between the frequency of BCR-ABL + interphase nuclei as determined on bone marrow preparations after 48 h cultivation (y-axis) and on directly prepared bone marrow smears (x-axis) in 70 patients.
Leukemia ABL-positive cells can occur due to cultivation depending on the cultivation conditions.
RT-PCR
In 214 patients RT-PCR was performed. In 130 patients a BCR-ABL transcript was detected after the first 35 cycles; in 45 cases RT-PCR became positive after the second round of 35 cycles. In 39 bone marrow samples nested RT-PCR was negative. If nested RT-PCR was negative, all other methods applied in this project were also negative.
Real-time PCR
In 94 cases real-time PCR was performed and a BCR-ABL/ABL ratio was calculated. In 12 bone marrow samples no transcript was detected by real-time PCR. In six of these patients conventional nested RT-PCR was also negative; in the other six cases BCR-ABL transcripts were detected by conventional RT-PCR after the second round of 35 cycles. If the BCR-ABL/ABL ratio was Ͼ0.8, conventional RT-PCR was already positive after the first 35 cycles.
Correlation of chromosome analysis, interphase-FISH, hypermetaphase-FISH, RT-PCR and real-time PCR
Correlations between all methods applied were highly significant (Table 3) . At low levels of Ph-positive metaphases HM-FISH was more sensitive than chromosome banding analysis. In 20 out of 104 cases with no Ph-positive metaphases in CA, HM-FISH detected 0.2 to 10% of BCR-ABLpositive metaphases. In cases with minimal residual disease the limited sensitivity of IP-FISH was obvious. According to the results of IP-FISH, 107 cases were judged as negative because of a percentage of positive signals below the cut-off level. However, in 17 of these samples (16%) HM-FISH detected BCR-ABL-positive metaphases (0.3-11%), and in eight cases (7%) CA detected Ph-positive metaphases (2.5-25%). Figure 2 shows, in detail, how many cases switched between response categories according to Kantarjian et al. 18 For IP-FISH values below 5% were assigned to the category of complete responders. Regarding the often used threshold of more than 35% Ph-positive metaphases for defining patients as non-responders to interferon therapy the analysis of our data show that only seven out of 313 patients (2.2%) would be assigned differently based on either chromosome banding analysis or HM-FISH: five patients would have been assigned as responders according to HM-FISH but as non- responders according to chromosome banding analysis, while two cases were responders on the basis of chromosome banding analysis but non-responders by HM-FISH. Analysis of HM-FISH and PCR data revealed that BCR-ABLpositive metaphases were only detected with HMF-FISH, if nested RT-PCR was positive.
In addition, 94 cases were evaluated with real-time PCR. The BCR-ABL/ABL calculated ratio showed a highly significant correlation with all other methods (Table 3 ). In Figure 3 the correlation between real-time PCR and chromosome analysis is presented. Although the correlation is very good a wide range in the BCR-ABL/ABL ratio was observed especially in patients who showed 100% Ph-positive metaphases in chromosome analysis. Whether this variation in BCR-ABL transcription rate has a clinical impact has to be determined in clinical trials. Chromosome analysis is still the gold standard for diagnosis and follow-up studies in CML. Especially in good responders sensitivity of chromosome analysis is too low to detect residual disease. In 20% of cases that showed no Ph + metaphases in chromosome banding analysis, HM-FISH was able to detect BCR-ABL + metaphases. These data confirm the higher sensitivity of HM-FISH compared to chromosome banding analysis as has been reported before in a smaller study. 20 Furthermore, due to the higher number of analyzable metaphases with HM-FISH, results become statistically more reliable. Whether the prognosis of patients with complete remission according to HM-FISH is significantly better than those with complete remission according to CA but detectable BCR-ABL + metaphases in HM-FISH, has to be evaluated in clinical trials.
Our results confirm that cultivation can increase the proportion of BCR-ABL-positive interphase nuclei. 21 Although a high correlation (r = 0.86) was observed between IP-FISH performed on uncultivated compared to cultivated cells a tendency towards a higher number of BCR-ABL-positive interphase nuclei was determined on cells after cultivation. This was predominately observed in cases with BCR-ABL positivity Ͼ30%. Therefore, we cannot confirm the data of Cuneo et al, 22 who observed no differences in BCR-ABL positivity between IP-FISH performed on directly harvested or cultured cells. As differences in cultivation conditions have an impact on the results, a standardization of methods especially within clinical trials is needed to allow the comparison of treatment results.
Under conventional treatment with hydroxyurea, inter- feron-␣ or after autologous transplantation, interphase-FISH on bone marrow or blood smears is a reliable method to monitor therapy response. Several studies showed that results of interphase-FISH performed on blood cells tracked the corresponding percentages of BCR-ABL-positive interphase nuclei of bone marrow cells determined by FISH and of Ph + metaphases. [22] [23] [24] [25] Therefore, interphase-FISH performed on blood cells seems to be an appropriate method to monitor response to treatment. In our study the cut-off level for interphase-FISH was set at 5%. Newly available FISH probes allowed the reduction of the cut-off level below 0.1% as has been shown in two recently published studies. 26, 27 While these new probes can be used for the determination of Leukemia residual disease, the probes we had to use for this study are not suitable for this application.
Our data confirm that nested RT-PCR is more sensitive than HM-FISH and real-time PCR and is therefore the method of choice for the detection of minimal residual disease after allogeneic BMT, especially if HM-FISH and real-time PCR are negative. The proof of minimal residual disease is of clinical importance, as the detection of BCR-ABL transcripts after 6 or more months post BMT is associated with subsequent hematological relapse. 28 In conclusion, all four methods evaluated show a good correlation of results and are applicable for the determination of clinical response. If results between different methods are 
